# Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial

> **NCT05327556** · PHASE2 · TERMINATED · sponsor: **Boston Children's Hospital** · enrollment: 15 (actual)

## Conditions studied

- Hypotension

## Interventions

- **DRUG:** Epinephrine 0.5 mcg/kg
- **DRUG:** Epinephrine 1 mcg/kg

## Key facts

- **NCT ID:** NCT05327556
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-08
- **Primary completion:** 2025-05-16
- **Final completion:** 2025-05-16
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Funding constraints
- **Last updated:** 2026-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05327556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05327556, "Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial". Retrieved via MORVS 2026-10-25 from https://api.morvs.ai/clinical/NCT05327556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*